Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the ...

Shares of Aurora Cannabis Inc. ACB shed 1.40% to $6.33 Wednesday, on what proved to be an all-around mixed trading session ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

Aurora Cannabis Inc. (TSE:ACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. Three ...

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...

Aurora Cannabis Inc (TSX:ACB) is set to release its Q3 2025 earnings on Feb 5, 2025. The consensus estimate for Q3 2025 ...

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.20 per share a year ago.

Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 4,520,000 shares, a growth of 5 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aurora Cannabis Inc. closed 31.34% below its 52-week high of $9.35, which the company reached on April 30th.